These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

123 related items for PubMed ID: 12685511

  • 1. MEGX disposition in critically-ill trauma patients: subsequent assessments during the first week following trauma.
    Pea F, Licari M, Baldassarre M, Furlanut M.
    Fundam Clin Pharmacol; 2002 Dec; 16(6):519-25. PubMed ID: 12685511
    [Abstract] [Full Text] [Related]

  • 2. Liver function and splanchnic ischemia in critically ill patients.
    Maynard ND, Bihari DJ, Dalton RN, Beale R, Smithies MN, Mason RC.
    Chest; 1997 Jan; 111(1):180-7. PubMed ID: 8996014
    [Abstract] [Full Text] [Related]

  • 3. Effect of dopamine-induced changes in splanchnic blood flow on MEGX production from lidocaine in septic and cardiac surgery patients.
    Jakob SM, Ruokonen E, Rosenberg PH, Takala J.
    Shock; 2002 Jul; 18(1):1-7. PubMed ID: 12095126
    [Abstract] [Full Text] [Related]

  • 4. Lidocaine elimination and monoethylglycinexylidide formation in patients with chronic hepatitis or cirrhosis.
    Testa R, Campo N, Caglieris S, Risso D, Alvarez S, Arzani L, Giannini E, Lantieri PB, Celle G.
    Hepatogastroenterology; 1998 Jul; 45(19):154-9. PubMed ID: 9496506
    [Abstract] [Full Text] [Related]

  • 5. Lidocaine metabolite formation as a measure of liver function in patients with cirrhosis.
    Oellerich M, Burdelski M, Lautz HU, Schulz M, Schmidt FW, Herrmann H.
    Ther Drug Monit; 1990 May; 12(3):219-26. PubMed ID: 2349604
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Value of an extended monoethylglycinexylidide formation test and other dynamic liver function tests in liver transplant donors.
    Zotz RB, von Schönfeld J, Erhard J, Breuer N, Lange R, Beste M, Goebell H, Eigler FW.
    Transplantation; 1997 Feb 27; 63(4):538-41. PubMed ID: 9047147
    [Abstract] [Full Text] [Related]

  • 8. Differential effect of chronic renal failure on the pharmacokinetics of lidocaine in patients receiving and not receiving hemodialysis.
    De Martin S, Orlando R, Bertoli M, Pegoraro P, Palatini P.
    Clin Pharmacol Ther; 2006 Dec 27; 80(6):597-606. PubMed ID: 17178261
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Lignocaine metabolite formation: an indicator for liver dysfunction and predictor of survival in surgical intensive care patients.
    Schröter J, Wandel C, Böhrer H, Schmidt H, Böttiger BW, Martin E.
    Anaesthesia; 1995 Oct 27; 50(10):850-4. PubMed ID: 7485872
    [Abstract] [Full Text] [Related]

  • 11. Hepatic function as assessed by lidocaine metabolism in sickle cell disease.
    Gremse DA, Fillingim E, Hoff CJ, Wells DJ, Boerth RC.
    J Pediatr; 1998 Jun 27; 132(6):989-93. PubMed ID: 9627591
    [Abstract] [Full Text] [Related]

  • 12. [Multiple organ failure after severe trauma: predictable by the MEGX liver function test?].
    Pape D, Lehmann U, Oellerich M, Regel G.
    Langenbecks Arch Chir Suppl Kongressbd; 1996 Jun 27; 113():338-9. PubMed ID: 9101869
    [Abstract] [Full Text] [Related]

  • 13. Monoethylglycinexylidide as an early predictor of posttraumatic multiple organ failure.
    Lehmann U, Armstrong VW, Schütz E, Regel G, Pape D, Oellerich M.
    Ther Drug Monit; 1995 Apr 27; 17(2):125-32. PubMed ID: 7624899
    [Abstract] [Full Text] [Related]

  • 14. The effect of age on plasma MEGX concentrations.
    Orlando R, Palatini P.
    Br J Clin Pharmacol; 1997 Aug 27; 44(2):206-8. PubMed ID: 9278213
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Monoethylglycinexylide formation in assessing pediatric donor liver function.
    Rossi SJ, Schroeder TJ, Vine WH, A-Kader HH, Gremse DA, Ryckman FC, Pedersen SH, Pesce AJ, Balistreri WF.
    Ther Drug Monit; 1992 Dec 27; 14(6):452-6. PubMed ID: 1485364
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Use of hepatic lidocaine metabolism to monitor patients with chronic liver disease.
    Shiffman ML, Luketic VA, Sanyal AJ, Thompson EB.
    Ther Drug Monit; 1996 Aug 27; 18(4):372-7. PubMed ID: 8857553
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.